CellMed AG is a
BTG International group company
Product Applications
Aesthetics
We are developing a suite of products for aesthetic applications based on our biopolymer technology platform.
MDF-100
M-Gel
AlyCM18 Enzyme
CellBeads™
CellBeads™ have been specifically designed to address many of the challenges currently facing the development of stem cell therapeutic products:
- Immunogenicity
- Characterization
- Product Supply
- Mechanism of Action
- Delivery Efficiency
- Retention of cell therapy at site of disease
Encapsulation of cells in a biocompatible biomaterial is a powerful technology designed to overcome these issues facing regenerative medicine.
StemFix™
Stemfix™ Delivery System. Cell therapy delivery vehicle for efficient implant and immobilisation of cells.
We are developing a pioneering delivery vehicle for autologous and allogeneic cell therapies that addresses the challenges of delivery, retention and immune-response.
